Drugdiscovery >> Drug Development >> News
3248
Views
Gilead gains profit from controversial Hepatitis C drug - drugdiscovery.com
Gilead gains profit from controversial Hepatitis C drug - drugdiscovery.com


Gilead Sciences announced that its income almost tripled thanks to Sovaldi. The controverisal Hepatitis C drug produced over $2.27B income for the developers.
Read More >>


Tags: AIDS and Healthcare foundation, Hepatitis C, hepatitis C drug, gilead, gilead news, Sovaldi, gilead profit - April 24, 2014
Related Articles
914
Views
Hepatitis drug of Bristol-Myers Squibb received Breakthrough Therapy Designation from FDA Hepatitis drug of Bristol-Myers Squibb received Breakthrough Therapy Designation from FDA
DCV dual regimen, the investigational chronic Hepatitis drug of Bristol-Myers was given a Breakttrough Therapy designation. Daclatasvir and asunaprevir combination therapy is thought to be the guarana Read More >>

Tags: Birstol-Myers, drug, hepatitis

2402
Views
Gilead has a new drug for HIV-1 infection Gilead has a new drug for HIV-1 infection
Gilead has announced that European Comission has accepted its new medicine, Vitekta. Te medicine includes ritonavir-boosted protease inhibitor - but what new things can it give to patients? Read More >>

Tags: patients, portease, drug, HIV

2153
Views
Insights to current  hepatitis C treatment  research Insights to current hepatitis C treatment research
Experts at Boehringer Ingelheim are in the middle of phase III evaluations of their interferon- free treatment regimen of patients with genotype 1b. The results of phase two studies are very promising Read More >>

Tags: hepatitis C, genotype-1b, new treatment, interferon-free, Boehringer Ingelheim

3566
Views
Tragic story of China's hepatitis B vaccine Tragic story of China's hepatitis B vaccine
20 years ago eight children died in China because of a problem with hepatitis B vaccination. After long years, the country now seems to learnt the lesson. Read More >>

Tags: china, vaccine, hepatitis B

8376
Views
FDA asks for input on antibiotic drug discovery FDA asks for input on antibiotic drug discovery
A US Food and Drug Administration (FDA) taskforce working on advancing antibiotic drug development has outlined its initial areas of interest, and proposed a list of pathogens that could trigger exte Read More >>

Tags: antibiotic drug development, FDA, drug candidate

5385
Views
Electric controll of drug can prevent side-effects Electric controll of drug can prevent side-effects
Several drugs have side effects because they are active in those parts of the body where they should not be. A group of scientists created a "smart" implant, which might solve this problem. Read More >>

Tags: smart implant, scientists, side effects, drug development, electronic drug control

4792
Views
GSK's diabetes Drug got an FDA 'okay' GSK's diabetes Drug got an FDA 'okay'
Taneum, the diabetes drug of GSK has been given a green light by FDA. With this 'okay' sign the pharmaceutical company can enter new markets. Read More >>

Tags: pharmatimes,pharma news, Eperzan, approved, albiglutide, Tanzeum, GSK, drug development, pain, diabetes, diabetes drug, new treatment for diabetes.

7577
Views
SOLIAIR™ - Breathing Made Easy! SOLIAIR™ - Breathing Made Easy!
SOLIAIR™ is a blend of botanical extracts and a food supplement that can help patients in chronic respiratory diseases such as Asthma, Bronchitis, COPD and other respiratory infections! Read More >>

Tags: Drug Development,Drug Discovery,Medicine Development,COPD Treatment,Asthma Solution,Bronchitis Therapy,Respiratory Diseases,Lung Infections,Breathing Disorders,healthcare investment,Drug Innovation,

5559
Views
Orphan drug designation for DengueCide Orphan drug designation for DengueCide
FDA has approved orphan drug designation to DengueCide, NanoViricides’ drug candidate for the treatment of dengue and dengue hemorrhagic fever. Read More >>

Tags: DengueCide, dengue, hemorrhagic fever, drug,orphan drug, NanoViricides

2323
Views
Cytokinetics failed FDA's approval Cytokinetics failed FDA's approval
Cytokinetics' new ASÉ drug has failed clinical trials and was not approved by FDA. The drug has not reached the efficiency endpoint, therefore further research is going to be needed. Read More >>

Tags: drug, drug discovery, ASL drug, Cytokinetics asl drug, FDA approval, FDA approval of asl drugs.

MOST VIEWED
HOME | ABOUT | PRIVACY POLICY | TERMS & CONDITIONS | ADVERTISE | CONTACT
All rights reserved drugdiscovery.com 2013